stock.name

CRISPR Therapeutics AG

CRSP

Market Cap$5.98B
Close$

Compare CRISPR Therapeutics AG

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CRISPR Therapeutics AGCRISPR Therapeutics AG-38.90%-8%17.7-
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$85.61

Current Fair Value

20.6% upside

Undervalued by 20.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$5.98 Billion
Enterprise Value$4.29 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.94
Beta0.0
Outstanding Shares80,275,950
Avg 30 Day Volume1,768,434

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-38.93
PEG21.53
Price to Sales17.74
Price to Book Ratio3.09
Enterprise Value to Revenue11.55
Enterprise Value to EBIT-19.26
Enterprise Value to Net Income-28
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About CRISPR Therapeutics AG

CEO: Samarth Kulkarni